Potentially inappropriate medication use in community residential care facilities.
OBJECTIVE
To describe the prevalence of potentially inappropriate medication use in community residential care (CRC) facilities at baseline, describe exposure to potentially inappropriate drugs during the 1-year follow-up, and examine characteristics associated with potentially inappropriate use.


METHODS
A cohort study was conducted using 282 individuals aged >/=65 years entering a CRC facility in a 3-county area in the Puget Sound region of Washington State between April 1998 and December 1998 on Medicaid funding.


METHODS
Use of potentially inappropriate medications as defined by explicit criteria (e.g., drugs that should generally be avoided in the elderly because potential risks outweigh any potential benefits).


RESULTS
Sixty-two (22%) residents took a total of 75 potentially inappropriate medications at baseline. The most common agents used at baseline were oxybutynin (3.5%) and amitriptyline (3.5%). The incidence of new use of potentially inappropriate medications was 0.1/100 person-days during the follow-up period. Potentially inappropriate use was related to self-reported fair or poor health (adjusted OR 1.42; 95% CI 1.05 to 1.92) and number of prescription drugs (adjusted OR 1.12; 95% CI 1.05 to 1.19). In the Cox proportional hazard model, no characteristics predicted new potentially inappropriate medication use during the follow-up.


CONCLUSIONS
Potentially inappropriate medication use is common among residents in CRC facilities. A comprehensive periodic review may be beneficial for reducing potentially inappropriate use, especially for patients taking multiple drugs.
Gray
Shelly L
SL
School of Pharmacy, University of Washington, Seattle, WA 98195-7360, USA. slgray@u.washington.edu
Hedrick
Susan C
SC
Rhinard
Ellen E
EE
Sales
Anne E
AE
Sullivan
Jean H
JH
Tornatore
Jane B
JB
Curtis
Michael P
MP
D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D003625:Data Collection; D017723:Drug Utilization Review; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008484:Medicaid; D011446:Prospective Studies; D012112:Residential Facilities